CMIC CMO Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6,354

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 3

CMIC CMO General Information

Description

Provider of pharmaceutical contract development and manufacturing services intended to support the drug product lifecycle. The company's technology utilizes continuous manufacturing and specialized facilities for solid, semi-solid, and injectable preparations, enabling pharmaceutical companies to access formulation development, clinical trial material production, commercial manufacturing, analytical testing, and packaging services.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 1-3-1 Hamamatsucho
  • Minato-ku
  • Tokyo, 105-0013
  • Japan
+81
Primary Industry
Drug Discovery
Parent Company
Corporate Office
  • 1-3-1 Hamamatsucho
  • Minato-ku
  • Tokyo, 105-0013
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CMIC CMO Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CMIC CMO‘s full profile, request access.

Request a free trial

CMIC CMO Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of pharmaceutical contract development and manufacturing services intended to support the drug product lifecycl
Drug Discovery
Tokyo, Japan
6,354 As of 2023

Kagoshima, Japan
 

Osaka, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CMIC CMO Competitors (9)

One of CMIC CMO’s 9 competitors is Shin Nippon Biomedical Laboratories, a Corporation company based in Kagoshima, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Shin Nippon Biomedical Laboratories Corporation Kagoshima, Japan
Sumitomo Pharma Corporation Osaka, Japan
Tanabe Pharma Private Equity-Backed Osaka, Japan
Novartis Corporation Basel, Switzerland
Astellas Pharma Corporation Tokyo, Japan
You’re viewing 5 of 9 competitors. Get the full list »

CMIC CMO Patents

CMIC CMO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2014223946-A Production system and production method of ptp sheet Pending 25-Apr-2013

CMIC CMO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CMIC CMO Investments & Acquisitions (3)

CMIC CMO’s most recent deal was a Later Stage VC with ThinkLand for . The deal was made on 12-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ThinkLand 12-Jul-2021 Later Stage VC Medical Supplies
ThinkLand 15-Apr-2019 Later Stage VC Medical Supplies
CMIC CMO Ashikaga 01-Apr-2016 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view CMIC CMO’s complete investments and acquisitions history, request access »

CMIC CMO FAQs

  • When was CMIC CMO founded?

    CMIC CMO was founded in 2009.

  • Where is CMIC CMO headquartered?

    CMIC CMO is headquartered in Tokyo, Japan.

  • What is the size of CMIC CMO?

    CMIC CMO has 6,354 total employees.

  • What industry is CMIC CMO in?

    CMIC CMO’s primary industry is Drug Discovery.

  • Is CMIC CMO a private or public company?

    CMIC CMO is a Private company.

  • What is CMIC CMO’s current revenue?

    The current revenue for CMIC CMO is .

  • How much funding has CMIC CMO raised over time?

    CMIC CMO has raised $76.3M.

  • Who are CMIC CMO’s competitors?

    Shin Nippon Biomedical Laboratories, Sumitomo Pharma, Tanabe Pharma, Novartis, and Astellas Pharma are some of the 9 competitors of CMIC CMO.

  • When was CMIC CMO acquired?

    CMIC CMO was acquired on 17-Apr-2023.

  • Who acquired CMIC CMO?

    CMIC CMO was acquired by Dai Nippon Printing.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process